Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.53 |
| ▸ | NTSR2 | O95665 | 4/20 | 0.52 |
| ▸ | NTSR1 | P30989 | 4/20 | 0.52 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.48 |
| ▸ | LNPEP | Q9UIQ6 | 3/20 | 0.47 |
| ▸ | ANPEP | P15144 | 2/20 | 0.47 |
| ▸ | VIPR2 | P41587 | 2/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | NPY4R | P50391 | 1/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.46 |
| ▸ | CASP4 | P49662 | 1/20 | 0.46 |
| ▸ | CASP5 | P51878 | 1/20 | 0.46 |
| ▸ | CASP9 | P55211 | 1/20 | 0.46 |
| ▸ | CASP6 | P55212 | 1/20 | 0.46 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.46 |
| ▸ | CASP10 | Q92851 | 1/20 | 0.46 |
| ▸ | VIPR1 | P32241 | 1/20 | 0.45 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29679828 | 0.93 | F2 (0.52) | F2NTSR2NTSR1SORT1LNPEP | |
| SCHEMBL30092922 | 0.89 | NPY4R (0.54) | F2NTSR2NTSR1VIPR2NPY1R | |
| SCHEMBL30063663 | 0.89 | NTSR2 (0.54) | F2NTSR2NTSR1SORT1LNPEP | |
| SCHEMBL29462368 | 0.88 | VIPR2 (0.50) | F2NTSR2NTSR1VIPR2VIPR1 | |
| SCHEMBL30741250 | 0.88 | VIPR2 (0.56) | F2VIPR2CASP1CASP3CASP4 | |
| SCHEMBL30092917 | 0.88 | NPY4R (0.56) | F2NTSR2NTSR1NPY1RNPY2R | |
| SCHEMBL29973963 | 0.87 | F2 (0.52) | F2NTSR2NTSR1 | |
| SCHEMBL29974829 | 0.87 | F2 (0.52) | F2NTSR2NTSR1 | |
| SCHEMBL29974534 | 0.86 | NTSR2 (0.54) | F2NTSR2NTSR1SORT1NPY1R | |
| SCHEMBL29974987 | 0.86 | NTSR2 (0.54) | F2NTSR2NTSR1SORT1NPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240116984-A1 | MODIFIED PEPTIDES FOR THE INHIBITION OF ABNORMAL TAU ACCUMULATION | NATIONAL SCIENCE FOUNDATION | 2024-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240116984-A1 | MODIFIED PEPTIDES FOR THE INHIBITION OF ABNORMAL TAU ACCUMULATION | PRNP, MAPT, APP | F2 3097/4885NTSR2 1511/4885NTSR1 1640/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.